BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 29022960)

  • 21. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
    Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
    Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension.
    Stiebel-Kalish H; Kalish Y; Lusky M; Gaton DD; Ehrlich R; Shuper A
    Am J Ophthalmol; 2006 Aug; 142(2):279-83. PubMed ID: 16876509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ophthalmological symptoms of idiopathic intracranial hypertension: Importance for diagnosis and clinical course].
    Unsöld R
    Ophthalmologe; 2015 Oct; 112(10):808-13. PubMed ID: 26445770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
    Mikkilineni S; Trobe JD; Cornblath WT; De Lott L
    J Neuroophthalmol; 2019 Jun; 39(2):186-190. PubMed ID: 30153119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiculopathy as unusual presentation of idiopathic intracranial hypertension: A case report.
    Ragab O; Ghali A; Al-Malt A; Al-Ahwal S
    Clin Neurol Neurosurg; 2017 Dec; 163():81-83. PubMed ID: 29078127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unilateral papilledema in 'benign' intracranial hypertension (pseudotumor cerebri).
    Sher NA; Wirtschafter J; Shapiro SK; See C; Shapiro I
    JAMA; 1983 Nov; 250(17):2346-7. PubMed ID: 6632132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pseudotumor cerebri or idiopathic cranial hypertension. Neuro-ophthalmologic considerations].
    Roşca T
    Oftalmologia; 2002; 54(3):11-3. PubMed ID: 12723189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Idiopathic intracranial hypertension as a cause of headache].
    Farmen AH; Ringstad G; Kerty E
    Tidsskr Nor Laegeforen; 2016 Dec; 136(22):1895-1898. PubMed ID: 27929555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases.
    Brun BN; Aylward SC
    Semin Pediatr Neurol; 2021 Dec; 40():100922. PubMed ID: 34749916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal Manifestations of Idiopathic Intracranial Hypertension.
    Nichani P; Micieli JA
    Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic intracranial hypertension (pseudotumor cerebri).
    Wall M
    Curr Neurol Neurosci Rep; 2008 Mar; 8(2):87-93. PubMed ID: 18460275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increasing vision disorder].
    Kolakovic P; Landau K; Steiner A
    Praxis (Bern 1994); 1996 Feb; 85(9):283-6. PubMed ID: 8685573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence.
    Soiberman U; Stolovitch C; Balcer LJ; Regenbogen M; Constantini S; Kesler A
    Childs Nerv Syst; 2011 Nov; 27(11):1913-8. PubMed ID: 21538129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Idiopathic intracranial hypertension without headache detected during a routine health check].
    Sakushima K; Tsuji S; Niino M; Yabe I; Sasaki H
    Rinsho Shinkeigaku; 2008 Jun; 48(6):430-2. PubMed ID: 18616157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
    Cello KE; Keltner JL; Johnson CA; Wall M;
    J Neuroophthalmol; 2016 Mar; 36(1):6-12. PubMed ID: 26618282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
    Vosoughi AR; Margolin EA; Micieli JA
    J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Now you see it..
    Pendse S; Bilyk JR; Olivia C; Biousse V
    Surv Ophthalmol; 2008; 53(2):177-82. PubMed ID: 18348882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional visual loss in idiopathic intracranial hypertension.
    Ney JJ; Volpe NJ; Liu GT; Balcer LJ; Moster ML; Galetta SL
    Ophthalmology; 2009 Sep; 116(9):1808-1813.e1. PubMed ID: 19643491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
    Noda M; Sonoda Y; Takemoto M; Kira R
    No To Hattatsu; 2017 May; 49(3):207-10. PubMed ID: 30113799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri).
    Wall M; Hart WM; Burde RM
    Am J Ophthalmol; 1983 Nov; 96(5):654-69. PubMed ID: 6638133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.